دورية أكاديمية

Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.

التفاصيل البيبلوغرافية
العنوان: Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.
المؤلفون: Papi, Alberto, Chipps, Bradley E., Beasley, Richard, Panettieri Jr, Reynold A., Israel, Elliot, Cooper, Mark, Dunsire, Lynn, Jeynes-Ellis, Allison, Rees, Robert, Albers, Frank C., Cappelletti, Christy
المصدر: Therapeutic Advances in Respiratory Disease; 5/2/2024, p1-14, 14p
مصطلحات موضوعية: INHALERS, ASTHMA, RESEARCH personnel, ALBUTEROL, BUDESONIDE
مصطلحات جغرافية: NEW England
مستخلص: What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study. [ABSTRACT FROM AUTHOR]
Copyright of Therapeutic Advances in Respiratory Disease is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17534658
DOI:10.1177/17534666241232264